CN Patent
CN101854907A — 化妆用或皮肤药用的组合物及其用法和化妆方法
Assigned to Sederma SA · Expires 2010-10-06 · 16y expired
What this patent protects
本发明涉及一种化妆用或皮肤药用的组合物及其用法和化妆方法,该组合物具有羟基甲硫氨酸和三-氨基丙磺酸,可用于防止和/或处理诸如皮肤与皮下组织的松垂、皮肤弹性的下降、皮肤纹理的弛缓、坚固性和强壮性的下降、皮肤萎缩和密度下降,皱纹,褶皱和裂纹之类的皮肤老化的征候。
USPTO Abstract
本发明涉及一种化妆用或皮肤药用的组合物及其用法和化妆方法,该组合物具有羟基甲硫氨酸和三-氨基丙磺酸,可用于防止和/或处理诸如皮肤与皮下组织的松垂、皮肤弹性的下降、皮肤纹理的弛缓、坚固性和强壮性的下降、皮肤萎缩和密度下降,皱纹,褶皱和裂纹之类的皮肤老化的征候。
Drugs covered by this patent
- Daliresp (ROFLUMILAST) · Arcutis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.